|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.105 USD | -10.16% |
|
-0.45% | -81.94% |
| 30/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 30/06 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 26.44M 22.87M 21.36M 19.59M 36.85M 2.52B 37.43M 251M 98.34M 1.26B 99.28M 97.11M 4.17B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 26.44M 22.87M 21.36M 19.59M 36.85M 2.52B 37.43M 251M 98.34M 1.26B 99.28M 97.11M 4.17B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -10.16% | ||
| 1 week | -0.45% | ||
| Current month | -0.45% | ||
| 1 month | -27.30% | ||
| 3 months | -66.92% | ||
| 6 months | -74.94% | ||
| Current year | -81.94% |
| 1 week | 1.02 |  | 1.25 |
| 1 month | 1.02 | | 1.95 |
| Current year | 1.02 | | 7.05 |
| 1 year | 1.02 | | 9.22 |
| 3 years | 1.02 | | 11.99 |
| 5 years | 1.02 | | 11.99 |
| 10 years | 1.02 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 01/03/2015 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 01/02/2024 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 01/04/2015 |
Aaron Fletcher
CHM | Chairman | 46 | 01/04/2015 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 01/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/2/26 | Fiscal year | Chief Executive Officer | 665,984 | 2.8653% | ||
| 5/1/26 | Kairos Venture Investments LLC
| Sell | Company | 280,000 | 1.2046% | |
| 27/6/25 | Other | Director | 71,428 | 0.3657% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.16% | -0.45% | -86.31% | - | 26.44M | |
| +8.49% | +20.55% | +69.74% | +109.30% | 68.12B | |
| +1.25% | +2.44% | +32.55% | +72.63% | 55.18B | |
| -1.09% | +32.96% | +19.95% | +499.45% | 28.63B | |
| +2.72% | +3.41% | -15.88% | -4.90% | 23.53B | |
| +10.83% | +18.38% | +52.76% | +4.58% | 23.99B | |
| +6.50% | +7.56% | +38.20% | -21.33% | 18.45B | |
| -3.88% | +16.98% | +199.30% | +354.30% | 15.83B | |
| +6.20% | +11.51% | +34.94% | +681.88% | 16.44B | |
| +3.58% | +1.96% | +44.61% | +167.01% | 13.4B | |
| Average | +2.44% | +10.47% | +38.99% | +206.99% | 26.36B | |
| Weighted average by Cap. | +4.36% | +13.09% | +49.47% | +168.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | USD 1.105 | -10.16% | 203,570 |
| 06/08/26 | USD 1.230 | +8.85% | 186,956 |
| 05/08/26 | USD 1.130 | +0.89% | 176,619 |
| 04/08/26 | USD 1.120 | +5.66% | 309,766 |
| 03/08/26 | USD 1.060 | -4.50% | 174,798 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.105USD
Average target price
9.978USD
Spread / Average Target
+802.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
